3-Iodo-8-methyl-imidazo[1,2-a]pyridine-2-carboxylic acid ethyl ester, 95+%, 50mg

3-Fluoro-2-methylcinnamic acid, 250mg

2-BROMO-4-METHYLBENZO[D]THIAZOLE, 95.0%, 250mg

Methyl 2-hydroxy-2-phenylpropanoate, 95.0%, 100mg

6-Thia-2-azaspiro[3.4]octane 6,6-dioxide hydrochloride, 98%, 250mg

3-Bromo-5-chloro-4-methylpyridine, 95.0%, 5g

4-Bromo-4'-chloro-3'-methylbenzophenone, 97.0%, 1g

2-(2,4-DINITROPHENYL)ETHANOL, 97.0%, 5g

Microliter syringe GASTIGHT® series 1700 Point type 3, 500 µl, 1750 RNR, 1 piece

METHYL 3-(2-(HYDROXYMETHYL)-1H-INDOL-1-YL)PROPANOATE, 95.0%, 250mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyldec-9-enoic acid, 95.0%, 5g

4-(N,N-Diphenylamino)benzaldehyde, 95.0%, 25g

3-(3-Bromo-4-methoxyphenyl)propanoic acid, 98%, 5g